# Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction

> **NCT00392379** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 270 (actual)

## Conditions studied

- Smokeless Tobacco Use

## Interventions

- **DRUG:** Nicotine Lozenges
- **DRUG:** Placebo lozenge

## Key facts

- **NCT ID:** NCT00392379
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2013-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392379, "Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00392379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*